Bal Pharma Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting
12-11-2025 | 06:17 pm
12-11-2025 | 06:17 pm
Bal Pharma has announced a board meeting on November 12. Key decisions include approving the financial results for the quarter and half-year. Consolidated Q2 revenue reached ₹74.02 Cr, with net profit at ₹0.71 Cr. Dr. Bheekamchand Mukesh was appointed as an Independent Director.
No comments yet. Be the first to comment!
